Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Annals of Neurology Année : 2007

Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.

Résumé

OBJECTIVE: Glutamic acid decarboxylase (GAD) catalyzes the conversion of glutamic acid into GABA. GAD autoantibodies (GAD-Ab) have been described in diabetes mellitus and in diseases involving the central nervous system such as stiff-person syndrome and cerebellar ataxia. However, the pathogenic role of GAD-Ab in neurological diseases remains a matter of debate. METHODS: Using neurophysiological and neurochemical methods, we analyzed the effects of intracerebellar and paraspinal administration of GAD-Ab in rats. RESULTS: Intracerebellar administration of IgG from patients with GAD-Ab and neurological involvement (IgG-GAD) blocked the potentiation of the corticomotor response normally associated with trains of repetitive peripheral nerve stimulation. When injected in the lumbar paraspinal region, IgG-GAD induced continuous motor activity with repetitive discharges, abnormal exteroceptive reflexes, and increased excitability of anterior horn neurons, as assessed by F/M ratios. Furthermore, IgG-GAD significantly reduced the N-methyl-D-aspartate-mediated production of nitric oxide in cerebellar nuclei and impaired the synaptic regulation of glutamate after N-methyl-D-aspartate administration. These effects were not observed after administration of IgG from the following groups: (1) patients with GAD-Ab, diabetes mellitus, and without neurological complications; and (2) control patients. INTERPRETATION: These results indicate that stiff-person syndrome and cerebellar ataxia are the direct consequence of antibody-mediated neuronal dysfunction. Ann Neurol 2007;61:544-551.
Fichier principal
Vignette du fichier
effects_of_anti-Gad.pdf (3.11 Mo) Télécharger le fichier
Loading...

Dates et versions

inserm-00141558 , version 1 (07-09-2011)

Identifiants

Citer

Mario-Ubaldo Manto, Marie-Aline Laute, Michèle Aguera, Véronique Rogemond, Massimo Pandolfo, et al.. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.: GAD-Ab and cerebellar function. Annals of Neurology, 2007, 61 (6), pp.544-551. ⟨10.1002/ana.21123⟩. ⟨inserm-00141558⟩
89 Consultations
790 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More